Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

  • RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    • News

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

  • AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    • News

  • Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    • News

  • Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    • News

  • FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    • News

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

ECS penetrates New Zealand market with latest shipment to Nubu

  • In News
  • July 4, 2022
  • Jack Cornips
ECS penetrates New Zealand market with latest shipment to Nubu

The budding cannabis market in New Zealand continues to flourish as more Kiwis seek an alternative to standard pharmaceutical drugs.

Now, just because trends are shifting doesn’t mean it is easier for patients to gain access to cannabis medication. To open up the world of cannabis therapy, New Zealand’s largest cannabis wholesaler is creating a mainline to inject the nation with access to a wide range of therapeutic medicine and medical devices. 

With a distribution network encompassing pharmacies and specialty clinics spanning the country, Nubu Pharmaceuticals (formerly MW Pharma Ltd) are onboarding as many overseas medicinal cannabis cultivators to expand their network to distribute products to every corner of the country. 

Nubu landed its latest distribution deal with an Australian cannabis company, ECS Botanics (ASX: ECS), which manufactures and cultivates cannabis products in Victoria, Australia, for worldwide distribution.

ECS already secured a four-year contract worth A$1.75m with Nubu back in August 2021, but today have officially completed their first shipment to New Zealand following a successful application to register ECS marijuana strains, along with import and export permits in the country. In fact, this will be the first dried cannabis flower strain for inhalation granted for approval in New Zealand, which ECS anticipates will give them a significant competitive edge and a strong chance at dominating the virgin market. 

“This shipment demonstrates ECS’ high-quality products, as New Zealand has one of the highest barriers for entry for imported medicinal cannabis. At ECS, we proudly grow our cannabis naturally in soil. This ensures our flowers contain the full spectrum of primary and secondary metabolites for maximum therapeutic benefit. I am confident that our product will be as well received by New Zealand patients, as it has been by our Australian and overseas patients,” said ECS Managing Director, Nan-Maree Schoerie.

As this is the first year of the four-year contract, the Company will supply a minimum order of $250,000 worth of product in 2022 and $500,000 minimum orders for the following three years.

Having led the market with its first successful registration of dried cannabis strains, ECS is well-positioned to maximise growth in this sprouting industry, securing long-term contracts to guarantee products out the door. 

Upon releasing this news, ECS shares have popped more than 10% today to sit on $0.21 at the time of writing, but this follows a nearly two-year downtrend from $0.78 that has seen more than 70% of its value wiped. 

During the previous quarter, ECS Botanics successfully completed a second shipment to Lyphe Group based in the United Kingdom. The Company has also been progressing markets globally as they’re in the works to pierce the Polish and German markets as they seek registration and approval for its products.

  • About
  • Latest Posts
Jack Cornips
Trading Desk Assistant at Emerald Financial
Latest posts by Jack Cornips (see all)
  • UNITH delivers eSocial Worker for public health services across 14 countries - December 5, 2023
  • Novatti cashing out of Reckon investment, clears debt to simplify payments business - November 17, 2023
  • Novatti seizes opportunity in Australia’s cashless transition as revenues rise while expenses drop - October 30, 2023
  •  
  •  
  •  
  •  
  • asx ecs
  • cannabis
  • ECS
  • ECS Botanics
  • MW Pharma Ltd
  • New Zealand
  • Nubu Pharmaceuticals
  • weed
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Jack Cornips
Trading Desk Assistant at Emerald Financial
Latest posts by Jack Cornips (see all)
  • UNITH delivers eSocial Worker for public health services across 14 countries - December 5, 2023
  • Novatti cashing out of Reckon investment, clears debt to simplify payments business - November 17, 2023
  • Novatti seizes opportunity in Australia’s cashless transition as revenues rise while expenses drop - October 30, 2023

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Jack Cornips
Trading Desk Assistant at Emerald Financial
Latest posts by Jack Cornips (see all)
  • UNITH delivers eSocial Worker for public health services across 14 countries - December 5, 2023
  • Novatti cashing out of Reckon investment, clears debt to simplify payments business - November 17, 2023
  • Novatti seizes opportunity in Australia’s cashless transition as revenues rise while expenses drop - October 30, 2023
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.